CE vs IMA · rev $10.28B vs rev $9.2M
Celanese Corporation (CE) versus ImageneBio, Inc. (IMA) — a side-by-side from cached financials, not a winner call.
Celanese Corporation (CE) is a chemicals company listed on US.
ImageneBio, Inc. (IMA) is a biotechnology company listed on NASDAQ.
Latest reported CE revenue for 2024-12-31 was $10.28B. Net income was -$1.51B. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. CE currently screens at market cap $5.92B.
Latest reported IMA revenue for 2023-12-31 was $9.2M. Net income was -$68.2M. Revenue was down 41.3% from 2022-12-31 to 2023-12-31. IMA currently screens at market cap $64.7M.
CE currently screens at market cap $5.92B. IMA currently screens at market cap $64.7M.
Not investment advice. Open the CE and IMA stock pages for the full models.
Not investment advice.